Literature DB >> 7521860

Peptide motifs of HLA-A3, -A24, and -B7 molecules as determined by pool sequencing.

R Maier1, K Falk, O Rötzschke, B Maier, V Gnau, S Stevanović, G Jung, H G Rammensee, A Meyerhans.   

Abstract

Mesh：

Substances：

Year:  1994        PMID： 7521860     DOI： 10.1007/bf00189978

Source DB:  PubMed          Journal:  Immunogenetics        ISSN： 0093-7711            Impact factor:   2.846


× No keyword cloud information.
  24 in total

1.  The three-dimensional structure of HLA-B27 at 2.1 A resolution suggests a general mechanism for tight peptide binding to MHC.

Authors:  D R Madden; J C Gorga; J L Strominger; D C Wiley
Journal:  Cell       Date:  1992-09-18       Impact factor: 41.582

2.  Identification of self peptides bound to purified HLA-B27.

Authors:  T S Jardetzky; W S Lane; R A Robinson; D R Madden; D C Wiley
Journal:  Nature       Date:  1991-09-26       Impact factor: 49.962

Review 3.  Consensus motifs and peptide ligands of MHC class I molecules.

Authors:  K Falk; O Rötzschke
Journal:  Semin Immunol       Date:  1993-04       Impact factor: 11.130

4.  H2-restricted recognition of cloned HLA class I gene products expressed in mouse cells.

Authors:  J L Maryanski; R S Accolla; B Jordan
Journal:  J Immunol       Date:  1986-06-15       Impact factor: 5.422

5.  Dominant aromatic/aliphatic C-terminal anchor in HLA-B*2702 and B*2705 peptide motifs.

Authors:  O Rötzschke; K Falk; S Stevanović; V Gnau; G Jung; H G Rammensee
Journal:  Immunogenetics       Date:  1994       Impact factor: 2.846

6.  Allele-specific peptide ligand motifs of HLA-C molecules.

Authors:  K Falk; O Rötzschke; B Grahovac; D Schendel; S Stevanović; V Gnau; G Jung; J L Strominger; H G Rammensee
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-15       Impact factor: 11.205

7.  TAP1-dependent peptide translocation in vitro is ATP dependent and peptide selective.

Authors:  J C Shepherd; T N Schumacher; P G Ashton-Rickardt; S Imaeda; H L Ploegh; C A Janeway; S Tonegawa
Journal:  Cell       Date:  1993-08-13       Impact factor: 41.582

8.  Transformation of LMTK- cells with purified HLA class I gene. VI. Serological characterization of HLA-B7 and AW24 molecules.

Authors:  C Layet; P P Le Bouteiller; C N'guyen; P Mercier; F Rosa; M Fellous; D H Caillol; B R Jordan; F A Lemonnier
Journal:  Hum Immunol       Date:  1984-09       Impact factor: 2.850

9.  Specific lysis of human immunodeficiency virus type 1-infected cells by a HLA-A3.1-restricted CD8+ cytotoxic T-lymphocyte clone that recognizes a conserved peptide sequence within the gp41 subunit of the envelope protein.

Authors:  K Takahashi; L C Dai; T R Fuerst; W E Biddison; P L Earl; B Moss; F A Ennis
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-15       Impact factor: 11.205

10.  Selectivity of MHC-encoded peptide transporters from human, mouse and rat.

Authors:  F Momburg; J Roelse; J C Howard; G W Butcher; G J Hämmerling; J J Neefjes
Journal:  Nature       Date:  1994-02-17       Impact factor: 49.962
View more
  17 in total

1.  Sequence similarities of protein kinase peptide substrates and inhibitors: comparison of their primary structures with immunoglobulin repeats.

Authors:  J Kubrycht; J Borecký; K Sigler
Journal:  Folia Microbiol (Praha)       Date:  2002       Impact factor: 2.099

2.  A biochemical and structural analysis of genetic diversity within the HLA-A*11 subtype.

Authors:  Lenong Li; Weifeng Chen; Marlene Bouvier
Journal:  Immunogenetics       Date:  2005-05-04       Impact factor: 2.846

3.  Immediate-early transactivator Rta of Epstein-Barr virus (EBV) shows multiple epitopes recognized by EBV-specific cytotoxic T lymphocytes.

Authors:  S Pepperl; G Benninger-Döring; S Modrow; H Wolf; W Jilg
Journal:  J Virol       Date:  1998-11       Impact factor: 5.103

4.  Role of strong anchor residues in the effective binding of 10-mer and 11-mer peptides to HLA-A*2402 molecules.

Authors:  M Ibe; Y I Moore; K Miwa; Y Kaneko; S Yokota; M Takiguchi
Journal:  Immunogenetics       Date:  1996       Impact factor: 2.846

5.  The human leukocyte antigen-presented ligandome of B lymphocytes.

Authors:  Chopie Hassan; Michel G D Kester; Arnoud H de Ru; Pleun Hombrink; Jan Wouter Drijfhout; Harm Nijveen; Jack A M Leunissen; Mirjam H M Heemskerk; J H Frederik Falkenburg; Peter A van Veelen
Journal:  Mol Cell Proteomics       Date:  2013-03-12       Impact factor: 5.911

6.  An antigenic peptide produced by reverse splicing and double asparagine deamidation.

Authors:  Alexandre Dalet; Paul F Robbins; Vincent Stroobant; Nathalie Vigneron; Yong F Li; Mona El-Gamil; Ken-ichi Hanada; James C Yang; Steven A Rosenberg; Benoît J Van den Eynde
Journal:  Proc Natl Acad Sci U S A       Date:  2011-06-13       Impact factor: 11.205

7.  Alloreactive cytotoxic T-lymphocyte-defined HLA-B7 subtypes differ in peptide antigen presentation.

Authors:  K D Smith; D F Epperson; C T Lutz
Journal:  Immunogenetics       Date:  1996       Impact factor: 2.846

Review 8.  MHC ligands and peptide motifs: first listing.

Authors:  H G Rammensee; T Friede; S Stevanoviíc
Journal:  Immunogenetics       Date:  1995       Impact factor: 2.846

9.  Amino acid 95 causes strong alteration of peptide position Pomega in HLA-B*41 variants.

Authors:  Christina Bade-Doeding; David S DeLuca; Axel Seltsam; Rainer Blasczyk; Britta Eiz-Vesper
Journal:  Immunogenetics       Date:  2007-02-10       Impact factor: 2.846

10.  HLA-A*01:03, HLA-A*24:02, HLA-B*08:01, HLA-B*27:05, HLA-B*35:01, HLA-B*44:02, and HLA-C*07:01 monochain transgenic/H-2 class I null mice: novel versatile preclinical models of human T cell responses.

Authors:  Rachid Boucherma; Hédia Kridane-Miledi; Romain Bouziat; Michael Rasmussen; Tanja Gatard; Francina Langa-Vives; Brigitte Lemercier; Annick Lim; Marion Bérard; Lbachir Benmohamed; Søren Buus; Ronald Rooke; François A Lemonnier
Journal:  J Immunol       Date:  2013-06-17       Impact factor: 5.422
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.